Replies to post #16520 on BioCurex, Inc.(fka BOCX)

[Kag]

Opportunity Knocking,
"It is a UNIQUE cancer test in that it will test for all cancers with a tiny sample of saliva. Just the fact that recaf can now detect cancer in saliva is mindblowing."

Your quote above is very misleading. All that is factually known (refer to Dr. Pennington's statement in today's press release) is that late-stage, widespread (metastised) cancers, in a small test sample of people, was detected by a RECAF saliva test with the results showing some false positives. What is much more important, is whether the same RECAF saliva test can detect early-stage cancer? Whether it can or not is not known because cancer patients with early-stage cancers have not been tested yet. It is hardly mindblowing that a RECAF saliva test could detect, with some false positives, cancer in patients who have late-stage, widespread cancer. Are you having difficulty understanding what was written in today's press release, or are you just trying to pump the stock? kag